Home > Insider Trading > Filing (0001477932-16-009673)

Filing Details

Accession Number:: 0001477932-16-009673
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2016-04-12 17:17:22
Reporting Period:: 2016-03-30

Filing Date:: 2016-04-12
Accepted Time:: 2016-04-12 17:17:22
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1506251	Citius Pharmaceuticals Inc.	CTXR	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1463414	L Leonard Mazur	C/O Citius Pharmaceuticals, Inc. 63 Great Road Maynard MA 01754		No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2016-03-30	5,000,000	$0.60	5,457,143	No	4	P	Direct
Common Stock	Acquisiton	2016-03-30	15,116,746	$0.00	20,116,746	No	4	J	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	J	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Price	Price - 2
Common Stock	Warrant to Purchase Common Stock	Acquisiton	2016-03-30	$0.00	$0.41
Common Stock	Warrant to Purchase Common Stock	Acquisiton	2016-03-30	$0.00	$0.66
Common Stock	Warrant to Purchase Common Stock	Acquisiton	2016-03-30	$0.00	$0.50
Common Stock	Warrant to Purcahse Common Stock	Acquisiton	2016-03-30	$0.00	$0.66
Common Stock	Warrant to Purchase Common Stock	Acquisiton	2016-03-30	$0.00	$0.50
Common Stock	Warrant to Purchase Common Stock	Acquisiton	2016-03-30	$0.00	$0.50
Common Stock	Warrant to Purchase Common Stock	Acquisiton	2016-03-30	$0.00	$0.50
Common Stock	Warrant to Purchase Common Stock	Acquisiton	2016-03-30	$0.00	$0.50
Common Stock	Warrant to Purchase Common Stock	Acquisiton	2016-03-30	$0.00	$0.41

Remaning Holdings	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
3,594,217	No	4	J	Direct
3,668,978	No	4	J	Direct
4,197,149	No	4	J	Direct
4,244,707	No	4	J	Direct
4,566,457	No	4	J	Direct
4,866,420	No	4	J	Direct
5,071,600	No	4	J	Direct
5,134,748	No	4	J	Direct
5,406,333	No	4	J	Direct

Footnotes

Represents shares of the Issuer issued pursuant to that certain Agreement and Plan of Merger (the "Merger Agreement") dated as of March 30, 2016 by and among the Issuer, Citius LMB Acquisition Corp., a Delaware corporation and wholly-owned subsidiary of the Issuer and Leonard-Meron Biosciences, Inc., a Delaware corporation ("LMB"). Pursuant to the terms of the Merger Agreement, each share of common stock of LMB and each convertible note of LMB was converted into shares of the Issuer's common stock.
On June 12, 2014, the Reporting Person was granted a five-year warrant to purchase 162,500 shares of LMB common stock at an exercise price of $0.75 per share. Pursuant to the Merger Agreement, the warrant was converted into a warrant to purchase 294,217 shares of the Issuer's common stock at a per share exercise price of $0.41. The warrant is fully vested and exercisable immediately.
Includes an option to purchase 3,300,000 shares of the Issuer's common stock at an exercise price of $0.45 per share granted to the Reporting Person on September 12, 2014 pursuant to the Issuer's 2014 Stock Incentive Plan. The option was previously reported on a Form 3 filed with the Commission on behalf of the Reporting Person on October 28, 2015 and amended on April 12, 2016.
On January 8, 2015, the Reporting Person was granted a five-year warrant to purchase 41,292 shares of LMB common stock at an exercise price of $1.20 per share. Pursuant to the Merger Agreement, the warrant was converted into a warrant to purchase 74,761 shares of the Issuer's common stock at a per share exercise price of $0.66. The warrant is fully vested and exercisable immediately.
On August 18, 2015, the Reporting Person was granted a five-year warrant to purchase 291,717 shares of LMB common stock at an exercise price $0.90 per share. Pursuant to the Merger Agreement, the warrant was converted into a warrant to purchase 528,171 shares of the Issuer's common stock at a per share exercise price of $0.50. The warrant is fully vested and exercisable immediately.
On September 30, 2015, the Reporting Person was granted a five-year warrant to purchase 26,267 shares of LMB common stock at an exercise price of $1.20 per share. Pursuant to the Merger Agreement, the warrant was converted into a warrant to purchase 47,558 shares of the Issuer's common stock at a per share exercise price of $0.66. The warrant is fully vested and exercisable immediately.
On November 2, 2015, the Reporting Person was granted a five-year warrant to purchase 172,184 shares of LMB common stock at an exercise price of $0.90 per share. Pursuant to the Merger Agreement, the warrant was converted into a warrant to purchase 311,750 shares of the Issuer's common stock at a per share exercise price of $0.50. The warrant is fully vested and exercisable immediately.
On November 20, 2015, the Reporting Person was granted a five-year warrant to purchase 171,197 shares of LMB common stock at an exercise price of $0.90 per share. Pursuant to the Merger Agreement, the warrant was converted into a warrant to purchase 309,963 shares of the Issuer's common stock at a per share exercise price of $0.50. The warrant is fully vested and exercisable immediately.
On January 8, 2016, the Reporting Person was granted a five-year warrant to purchase 113,324 shares of LMB common stock at an exercise price of $0.90. Pursuant to the Merger Agreement, the warrant was converted into a warrant to purchase 205,180 shares of the Issuer's common stock at a per share exercise price of $0.50. The warrant is fully vested and exercisable immediately.
On March 14, 2016, the Reporting Person was granted a five-year warrant to purchase 34,877 shares of LMB common stock at an exercise price of $0.90 per share. Pursuant to the Merger Agreement, the warrant was converted into a warrant to purchase 63,148 shares of the Issuer's common stock at a per share exercise of $0.50. The warrant is fully vested and exercisable immediately.
On March 15, 2016, the Reporting Person was granted a five-year warrant to purchase 150,000 shares of LMB common stock at an exercise price $0.75 per share. Pursuant to the Merger Agreement, the warrant was converted into a warrant to purchase 271,585 shares of the Issuer's common stock at a per share price of $0.41. The warrant is fully vested and exercisable immediately.